4 terminated. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Terminated 4 |
| Phase 2 | 3 | Terminated 3 |
Follow Congenital Microtia: new trials by email Literature Review of Congenital Microtia trials Research Report on Congenital Microtia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long-Term Follow-Up Study of Unilateral Microtia Patients Implanted With AUR-201 AUR-201 - Microtia | Phase 1 / Phase 2 | Terminated | Auregen Biotherapeutics, SA | 1 | 2024-01-26 | 2025-11-21 |
| Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia AUR-201 - Microtia | Phase 1 / Phase 2 | Terminated | Auregen Biotherapeutics, SA | 3 | 2024-01-26 | 2025-11-21 |
| Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia (Australia) AUR-201 - Microtia | Phase 1 | Terminated | Auregen Biotherapeutics, SA | 2 | 2022-11-04 | 2025-11-19 |
| AuriNovo for Auricular Reconstruction AuriNovo - Microtia | Phase 1 / Phase 2 | Terminated | 3DBio Therapeutics | 2 | 2021-08-09 | 2024-03-04 |
Congenital Abnormalities (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Ear Diseases (4) · Otorhinolaryngologic Diseases (4)
Auregen Biotherapeutics, SA (3) · 3DBio Therapeutics (1)
United States (3) · Australia (1)